Gary W. Bong

425 total citations
11 papers, 318 citations indexed

About

Gary W. Bong is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Gary W. Bong has authored 11 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Gary W. Bong's work include Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Chemokine receptors and signaling (3 papers). Gary W. Bong is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Chemokine receptors and signaling (3 papers). Gary W. Bong collaborates with scholars based in United States. Gary W. Bong's co-authors include Gary S. Firestein, Sanna Rosengren, Thomas E. Keane, Eric S. Rovner, Bernardetta Nardelli, Harry P. Koo, Harry S. Clarke, Philip M. Murphy, H. Lee Tiffany and Yuling Li and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Journal of Leukocyte Biology.

In The Last Decade

Gary W. Bong

11 papers receiving 310 citations

Peers

Gary W. Bong

PRM

ONCOL

PHYSI

MB

IMMUN

James D. Young Canada

Djordje Grbic Canada

Eef Hoeben Belgium

Allison Ciolino United States

Gloria S.M. Yu United States

Joshua M. Kruger Israel

Hee‐Cheol Kim South Korea

Vincenzo Nardini Italy

C. Justin Van De Wiele United States

G Prosperini Italy

James D. Young Canada

Gary W. Bong

32 ×0.4

PRM

84 ×1.3

ONCOL

130 ×2.0

PHYSI

165 ×2.8

MB

9 ×0.2

IMMUN

Citations per year, relative to Gary W. Bong Gary W. Bong (= 1×) peers James D. Young

Countries citing papers authored by Gary W. Bong

Since Specialization

Citations

This map shows the geographic impact of Gary W. Bong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. Bong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. Bong more than expected).

Fields of papers citing papers by Gary W. Bong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary W. Bong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. Bong. The network helps show where Gary W. Bong may publish in the future.

Co-authorship network of co-authors of Gary W. Bong

This figure shows the co-authorship network connecting the top 25 collaborators of Gary W. Bong. A scholar is included among the top collaborators of Gary W. Bong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary W. Bong. Gary W. Bong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Bong, Gary W., Chad W.M. Ritenour, Adeboye O. Osunkoya, Michael T. Smith, & Thomas E. Keane. (2009). Evaluation of modern pathological criteria for positive margins in radical prostatectomy specimens and their use for predicting biochemical recurrence. British Journal of Urology. 103(3). 327–331. 24 indexed citations

2.

Bong, Gary W., et al.. (2008). Serum Testosterone Recovery After Cessation of Long-Term Luteinizing Hormone-Releasing Hormone Agonist in Patients with Prostate Cancer. Urology. 71(6). 1177–1180. 41 indexed citations

3.

Bong, Gary W. & Thomas E. Keane. (2007). Salvage options for biochemical recurrence after primary therapy for prostate cancer.. PubMed. 14 Suppl 1. 2–9. 3 indexed citations

4.

Bong, Gary W. & Eric S. Rovner. (2007). Sexual Health in Adult Men with Spina Bifida. The Scientific World JOURNAL. 7. 1466–1469. 28 indexed citations

5.

Bong, Gary W. & Eric S. Rovner. (2006). Vaginal erosion after hybrid midurethral sling placement. Urology. 68(6). 1343.e13–1343.e14. 3 indexed citations

6.

Bong, Gary W. & Harry P. Koo. (2004). The adolescent varicocele: to treat or not to treat. Urologic Clinics of North America. 31(3). 509–515. 21 indexed citations

7.

Grzegorzewski, Krzysztof, Xiao-Tao Yao, Brent L. Kreider, et al.. (2001). ANALYSIS OF EOSINOPHILS AND MYELOID PROGENITOR RESPONSES TO MODIFIED FORMS OF MPIF-2. Cytokine. 13(4). 209–219. 1 indexed citations

8.

Nardelli, Bernardetta, H. Lee Tiffany, Gary W. Bong, et al.. (1999). Characterization of the Signal Transduction Pathway Activated in Human Monocytes and Dendritic Cells by MPIF-1, a Specific Ligand for CC Chemokine Receptor 1. The Journal of Immunology. 162(1). 435–444. 55 indexed citations

9.

Nardelli, Bernardetta, et al.. (1999). Dendritic cells and MPIF-1: chemotactic activity and inhibition of endogenous chemokine production by IFN-γ and CD40 ligation. Journal of Leukocyte Biology. 65(6). 822–828. 26 indexed citations

10.

Bong, Gary W., Sanna Rosengren, & Gary S. Firestein. (1996). Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-D-aspartate receptors.. Journal of Clinical Investigation. 98(12). 2779–2785. 53 indexed citations

11.

Rosengren, Sanna, Gary W. Bong, & Gary S. Firestein. (1995). Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage.. The Journal of Immunology. 154(10). 5444–5451. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact